Exhibit 99

                          [Clinicor, Inc. Letterhead]


News Announcement

CONTACT:
Thomas P. O'Donnell                                     David C. Collins
President                                               Jaffoni & Collins
512/344-3357                                            Incorporated
                                                        212/505-3015  or
                                                        dccjci@aol.com

FOR IMMEDIATE RELEASE

CLINICOR ELECTS BOARD OF DIRECTORS, PREVIEWS FIRST QUARTER RESULTS, NAMES JAMES 
W. CLARK AS CFO

Austin, TX  (May 13, 1997) -- Clinicor, Inc. (OTCBB: CLCR) announced, at its 
annual shareholders' meeting held here today, that a slate of five directors had
been elected to the Company's Board of Directors.  Additionally, Price 
Waterhouse LLP was ratified as the Company's auditors for the year ending 
December 31, 1997.  Clinicor also announced that James W. Clark, Jr., CPA, 45, 
has been named Chief Financial Officer of the Company, effective immediately.

At the shareholders meeting Clinicor management previewed its first quarter 
results, highlighting the continued growth of its revenue and backlog.  Gross 
revenues for the first quarter ended March 31, 1997 are expected to increase to 
approximately $2.5 million, compared to $855,000 in the comparable year-ago
period, a 192% increase. The net loss applicable to common stock, after giving 
effect to preferred stock dividends, is expected to be approximately $600,000, 
or approximately $0.15 per share, compared to a net loss applicable to common 
stock of $75,000, or $0.02 per share, in the year-ago first quarter. The 
increase in the net loss applicable to common stock is largely due to increased 
SG&A expenses related to the expansion of Clinicor's professional and 
administrative staff and infrastructure, in support of its growing backlog, and 
its sales and marketing effort.  This increase  more than offset a modest 
increase in gross profit margins.

The Company also announced it is currently seeking additional equity capital and
bank financing to fund its growing base of contract activity and increased sales
and marketing efforts.  In that connection, Clinicor also reported that it has 
withdrawn its November 1996 application for listing on the Nasdaq SmallCap 
Market and that it intends to re-apply for listing on the SmallCap Market 
following completion of the proposed financing.

 
Jim Clark joins Clinicor from Bay Resources, Inc., a Florida-based computer 
leasing and consulting firm, where he served as Vice President of Finance, 
Treasurer and Chief Financial Officer. While at Bay Resources, Mr. Clark oversaw
all of the Company's financial management, credit line development, leasing and 
debt financing activities. Mr. Clark also developed the business plan that 
enabled the Company to grow revenues from $12 million to $85 million over his 
eight year tenure.

Prior to joining Bay Resources, Mr. Clark was a management consultant providing 
merchant banking services and initiating venture capital investments on behalf 
of medium-sized Florida companies. From 1979 to 1985, Mr. Clark served first as 
Chief Financial Officer and then as a consultant to Crime Control, Inc., an 
Indiana-based home security alarm and services firm. Mr. Clark oversaw a 15-fold
increase in Crime Control's revenues and its 1982 initial public offering. As 
CFO, Mr. Clark managed the Company's accounting and tax departments, its 
management information systems, its merger and acquisition program and its 
investor relations function, and later oversaw two additional offerings of 
common stock. Mr. Clark began his career at the Indianapolis, Indiana offices of
Ernst & Young, having received a Bachelor of Arts degree from Butler University.
He is a Certified Public Accountant.

Mr. O'Donnell commented, "We are extremely pleased with our operating progress 
and the appointment of Jim Clark as CFO. Jim brings to Clinicor a valuable skill
set, a broad base of experience and most importantly, a successful track record 
of helping fast growing companies to manage their growth and increase 
profitability. His financial management skills, public company experience, 
history of successful business plan execution, and ability to build long-term 
banking and finance relationships are of tremendous value to Clinicor as we seek
to expand our market share in the CRO industry." 

Clinicor, Inc., an Austin, Texas-based contract research organization (CRO), 
provides Phase I through Phase IV clinical trials management, including patient 
recruitment, monitoring, data management services and regulatory consultation, 
to the pharmaceutical, biotechnology and medical device industries. Clinicor 
differentiates itself through a unique operating model that emphasizes its 
specialized patient recruitment, patient management and study monitoring 
capabilities. Clinicor's approach accelerates the recruitment of suitable
patient populations and enhances the accuracy of clinical data, resulting in
high caliber clinical trial services offering significant value to the sponsor.

                                       2

 
The forward-looking statements in this press release involve risks and 
uncertainties, including, but not limited to, quarterly fluctuations in results,
the timing and performance of contracts, the management of growth, and other 
risks.  Actual results may differ materially from management expectations.  
Detailed information concerning factors that could cause actual results to 
differ materially from management's expectations is available in the 
"Management's Discussion and Analysis" portion of the Company's recent report on
Form 10-KSB for the year ended December 31, 1996.

                                       3